EUVIMEDEUVIMED entdecken
Crossref

A Novel Nomogram for Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Ziwen Lu, Yibo Sun, Yifei Wang, Yueyi Sun, Yuanming Qiang, Guangming Li

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.07.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Ziwen Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery Center, Beijing You'An Hospital, Capital Medical University, Beijing Institute of Hepatology, Beijing, China; Clinical …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Nomograms, Liver Neoplasms. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) remains a critical issue with limited predictive accuracy. We aimed to develop a nomogram integrating clinical indicators, pathological factors, serum tumor markers, and inflammatory markers. METHODS: Retrospective data of patients with HCC were collected at Beijing You'an Hospital from January 2015 to December 2022. Univariate and multivariate Cox regression analyses were performed to identify and construct the prognostic nomogram. Receiver operating characteristic (ROC) curves, Kaplan-Meier curves, decision curve analyses, and calibration diagrams were used to assess the predictive capacity of the nomogram. RESULTS: A total of 395 patients with HCC after LT were included in the present study. The nomogram model was established based on seven independent risk factors: LT criteria, hepatic steatosis, microvascular invasion (MVI), Edmondson-Steiner grade, creatinine (Cr), aspartate aminotransferase (AST), and systemic immune-inflammation index (SII). The area under the curve (AUC) for 1 year, 3 years, and 5 years predicting postoperative recurrence-free survival (RFS) was 0.811, 0.826, and 0.828. Decision curve analyses (DCAs) showed excellent clinical utility for the model. CONCLUSIONS: We developed a novel, simple, and clinically relevant nomogram for early prediction and diagnosis of post-transplant HCC recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver TransplantationNomogramsLiver NeoplasmsNeoplasm Recurrence, LocalHumansMaleMiddle AgedRetrospective StudiesFemaleRisk FactorsAdultRisk AssessmentPredictive Value of Tests

Autor:innen und Institutionen

  • Department of General Surgery Center, Beijing You'An Hospital, Capital Medical University, Beijing Institute of Hepatology, Beijing, China; Clinical Center for Liver Cancer, Capital Medical University, Beijing, China.
  • Department of General Surgery Center, Beijing You'An Hospital, Capital Medical University, Beijing Institute of Hepatology, Beijing, China; Clinical Center for Liver Cancer, Capital Medical University, Beijing, China. E…

Zitieren

APA

Lu, Z., Sun, Y., Wang, Y., Sun, Y., Qiang, Y., & Li, G. (2025). A Novel Nomogram for Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.07.026

Vancouver

Lu Z, Sun Y, Wang Y, Sun Y, Qiang Y, Li G. A Novel Nomogram for Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.07.026

BibTeX
@article{Lu2025,
  author = {Lu, Ziwen and Sun, Yibo and Wang, Yifei and Sun, Yueyi and Qiang, Yuanming and Li, Guangming},
  title = {A Novel Nomogram for Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.07.026}
}
Kostenlos starten →